CE-245677

SynDRA canonical compound SYN0038629 — structure-anchored drug synonym record

Clinical phase	Phase 1
Primary target(s)	NTRK1 \| NTRK2 \| TEK
Mechanism of action	tie tyrosine kinase inhibitor
Indication	breast cancer
Disease area	oncology

All known targets

TEK
NTRK1
NTRK2

Mechanisms of action (all sources)

TEK INHIBITOR
Tyrosine-protein kinase TIE-2 inhibitor
tie tyrosine kinase inhibitor

Cross-references

PubChem CID: 16048643
ChEMBL: CHEMBL3910075

Synonyms

UNII-GMH17J9LHL
GMH17J9LHL
CE 245677 [WHO-DD]
RefChem:124156
C24H22Cl2N6O3
orb1308468
SCHEMBL1940683
SCHEMBL29392014
VFCRSIORGUNNGT-UHFFFAOYSA-N
SDB89997
AKOS037649227
BS-17402
DA-62168
HY-112423
CS-0046037
D80416
T14921

Look up CE-245677 in the interactive SynDRA portal →